PRIMARY INFORMATION |
---|
ID | 1209 |
PMID | 14757511 |
Year | 2004 |
Sequence | pGlu-HWSYGLRPG |
Name | LHRH |
Length | 10 |
N-Terminal Modification | Free |
C-Terminal Modification | Amidation |
Linear/ Cyclic | Cyclic |
Chirality | L |
Chemical Modification | pGlu= Pyroglutamic acid |
Origin of Peptide | Synthetic |
Nature of Peptide/Cargo | Peptides containing closely juxtapositioned cationic and lipohilic residues are able to inhibit their own transport across the skin even under the influence of iontophoretic current. |
Mechanism | Major mechanism of iontophoretic transdermal delivery of large peptides is the convective solvent flow. |
Cargo Sequence/Structure | None |
Name of cargo
| Not applicable |
Assay | HPLC |
Enhancer | Transdermal iontophoresis |
Properties of enhancer | Transdermal iontophoresis utilizes low current/voltage electrostatic repulsion and electroosmotic solvent flow |
Concentration | 0.5 mM of peptide in a buffer which consisted of 25 mM Hepes and 150 mM NaCl (pH 7.4) |
Incubation time | Iontophoretic experiments lasted for 24 h |
Tissue permeability (value with units) | LHRH flux= 12.39 ± 5.32 µg h−1 cm−2 at 75% pulsed DC (500 Hz) |
Tissue Sample | Epidermis of human cadaver skin |
Ex vivo/In vivo/In vitro | ex vivo |
SECONDARY INFORMATION |
---|
STRUCTURE | |
SMILES | N.A. |